Richard Segiel, Jr. has been appointed vice president of business development for Almac’s Clinical Services Business Unit in the U.S. He has 23 years of experience in the contract pharmaceutical development sector. In his new role, he will focus on developing new business, maintaining existing business, and developing partnerships.
 
Prior to joining the company, Mr. Segiel held a number of business development and operational positions at Intertek Pharmaceutical Services, MDS Tricon, Celsis Analytical Services, and Pharmakon Research International. Most recently, he served as business development director of Intertek Pharmaceutical Services, where he had direct responsibility for all business development and sales initiatives for the company’s Chemical and Pharmaceutical Division.
 
“Richard brings a compelling mix of business development, operational, and financial experience that will further strengthen Almac’s leadership team. This skill set is key to delivering on our core objective of enhancing our U.S. client relationships, further developing our commitment to customer service, and helping achieve true strategic partnerships,” said Martin Lamb, global vice president of business development at Almac.